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Background: The total serum prostate-specific antigen has been used as a screening tool to determine prostate
health and is routinely done after a clinical exam which may include a digital rectal exam. The complexed
prostate-specific antigen is a portion of the total prostate-specific antigen and may be a better indicator for
prostate health. The purpose of this paper is to evaluate the effect that the digital rectal exam has on both the
total prostate-specific antigen and the complexed prostate-specific antigen. The evidence will be evaluated
using the GRADE system.
Method: An exhaustive search of available medical literature was conducted using Medline, Web of Science,
Cochrane Systematic Reviews and CINAHL.
Results: There were four studies included in the review. The change in total and complexed prostate-specific
antigen serum values in ng/mL post digital rectal examination was evaluated across the studies. Due to the
fact that the complexed prostate-specific antigen is a subset of the total prostate-specific antigen the
consequences of the digital rectal examination was compared using a percent change.
Conclusion: The complexed prostate-specific antigen is affected less by the digital rectal exam and would
indicate that it may be a more reliable marker for prostate health compared to the total prostate-specific
antigen. This recommendation needs to be used with caution as the overall GRADE of evidence was
considered low and additional research is likely to have an impact on the confidence of the
recommendation[TC1] .
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ABSTRACT 
 
Background:  The total serum prostate-specific antigen has been used as a 
screening tool to determine prostate health and is routinely done after a clinical 
exam which may include a digital rectal exam.  The complexed prostate-specific 
antigen is a portion of the total prostate-specific antigen and may be a better 
indicator for prostate health.  The purpose of this paper is to evaluate the effect 
that the digital rectal exam has on both the total prostate-specific antigen and the 
complexed prostate-specific antigen.  The evidence will be evaluated using the 
GRADE system. 
 
Method:  An exhaustive search of available medical literature was conducted 
using Medline, Web of Science, Cochrane Systematic Reviews and CINAHL. 
 
Results:  There were four studies included in the review.  The change in total and 
complexed prostate-specific antigen serum values in ng/mL post digital rectal 
examination was evaluated across the studies.  Due to the fact that the 
complexed prostate-specific antigen is a subset of the total prostate-specific 
antigen the consequences of the digital rectal examination was compared using 
a percent change. 
 
Conclusion:  The complexed prostate-specific antigen is affected less by the 
digital rectal exam and would indicate that it may be a more reliable marker for 
prostate health compared to the total prostate-specific antigen.  This 
recommendation needs to be used with caution as the overall GRADE of 
evidence was considered low and additional research is likely to have an impact 
on the confidence of the recommendation. 
 
Keywords:  Manipulation, massage, prostate-specific antigen, PSA, digital rectal 
examination, DRE 
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INTRODUCTION 
Background 
The American Cancer Society (ACS, 2010) reports prostate cancer to be 
the second leading cause of death in males behind lung cancer and that one out 
of six males will be diagnosed with prostate cancer during their lifetime.  They 
also report that 217,730 cases of prostate cancer were diagnosed in 2010 and 
that one out 36 males will eventually die from prostate cancer.   
The United States Preventive Services Task Force (USPSTF) does not 
currently recommend regular prostate screening and the ACS recommends 
routine screening beginning at the age of 50 in healthy adult males.  If there is an 
increased risk of prostate cancer, the ACS recommends screening to begin as 
soon as 40 (USPSTF, 2008 & American Cancer Society, 2010).   
The digital rectal exam (DRE) used in conjunction with the prostate-
specific antigen (PSA) continue to be the most widely used screening tool to 
evaluate disorders of the prostate including cancer.  However, the sensitivity and 
specificity of the PSA screening test is approximately 20 to 40 percent so it is not 
the ideal test that is used for a tumor marker (Fischbach & Dunning, 2009).  The 
PSA is a glycoprotein.  When referring to PSA the total prostate-specific antigen 
(tPSA) is what is actually being measured and there are multiple components 
that comprise the tPSA.  Of those components, approximately 65-95% is bound 
to α 1-antichymotrypsin (ACT), as complexed prostate-specific antigen (cPSA).  
The complexed form is made up of other types including α 1-protease inhibitor, 
and α 2-macroglobulin, protein C inhibitor, interα 1-trypsin inhibitor, and pregnancy 
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zone protein.  The tPSA, that is typically measured, is made up of both the 
complexed and free forms (Long et. al, 2006).   
It has been shown that the DRE has little effect on tPSA levels (Hoffman, 
2010) and can be measured directly after the examination.   However, it has 
been suggested that the cPSA is less sensitive to external influences compared 
to the tPSA, and, therefore, is a more reliable indicator for prostatic disorders. 
Purpose of the Study 
Since the PSA is currently the best screening tool available to date, it is 
important that the test be as accurate as possible.  Many clinicians perform a 
DRE and request a PSA afterwards.  The purpose of this paper is to perform a 
systematic review of the literature on the effect that the DRE has on the total and 
complexed PSA using the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) tool developed by the GRADE Working 
Group (Guyatt et al., 2008). 
METHOD 
 
An extensive literature search was performed using Medline, Web of 
Science, Cochrane Systematic Reviews and CINAHL. These databases were 
accessed through the Pacific University Library system. The keywords searched 
were “manipulation”, “massage”, “PSA”, “prostate-specific antigen”, “DRE” and 
“digital rectal examination,” individually and in combination. The search was 
limited to human subjects, articles published in English since 2000.  A total of 15 
articles were identified on the original search.  Duplicate and unrelated articles 
were eliminated and three articles remained. A reference search was done in the 
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Web of Science and one additional article was found that could be included in the 
study.  The articles identified were observational studies that were included in the 
final review. 
RESULTS  
The first study reviewed was performed by Tarhan et al. (2005) and they 
set out to evaluate the effect a prostatic massage had on cPSA levels compared 
to tPSA and free PSA (fPSA) levels after various prostatic manipulations.  The 
study included 51 men that had a mean age of 63.33 +/- 1.28 years.  Of the 51 
men in the analysis, 35 of the men had benign prostatic hyperplasia (BPH), 
seven had prostate cancer, and nine had prostatitis.  The men had their prostate 
massaged for approximately one minute by the same examiner.  The PSA serum 
samples were taken 30 minutes before and 30 minutes after the prostatic 
massage.  According to their diagnosis, the serum values in ng/mL before and 
after manipulation are as follows for tPSA:  BPH before 4.09 +/- 0.78, BPH after 
8.02 +/- 1.33, prostate cancer before 18.21 +/- 6.64, prostate cancer after 19.91 
+/- 6.62, prostatitis before 2.06 +/- 0.46, and prostatitis after 6.32 +/- 1.19.  
Similar results were then reported using the cPSA:  BPH before 2.62 +/- 0.53, 
BPH after 2.80 +/- 0.53, prostate cancer before 12.52 +/- 3.68, prostate cancer 
after 12.11 +/- 3.53, prostatitis before 1.40 +/- 0.35, and prostatitis after 1.90 +/- 
0.36.  Tarhan et al. (2005) concluded that prostatic massage increased cPSA 
levels, but not to the extent tPSA and fPSA levels were increased. 
The next study reviewed was performed by Long et al. (2006) and 
included 113 men in the study.  They performed several forms of prostatic 
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manipulation in an effort to compare the effect the treatment has on cPSA and 
tPSA.  The men received various forms of prostatic manipulation which included 
DREs, flexible cystoscopy, rigid cystoscopy, prostate biopsy and transurethral 
resection of the prostate.  Of the 113 men in the study 34 had DREs.  The DRE 
was performed in the left lateral position by the same clinician.  The mean age of 
the men was 67 and their ages ranged from 29 to 87.  Their ages were not 
broken out by the type of manipulation they had undergone.  The PSA serum 
samples were taken 20 minutes before and after the DRE.  The results were 
presented by how much the measurement changed using a paired t-test.  The 
change in tPSA in ng/mL was 0.81 +/- 0.84 and the change in cPSA was 0.63 +/- 
0.74.  The authors concluded that cPSA levels are less vulnerable to prostatic 
manipulation than are the tPSA levels.   
Lynn et al. (2000) study was reviewed.  They had 92 men in the study with 
a mean age of 68.6 years and they set out to collect data on the effects that 
various forms of prostatic manipulation has on cPSA levels.  The men received 
different forms of prostatic manipulation that included prostatic biopsy, flexible 
cystoscopy and DRE.  Of the 92 men, 16 were evaluated after a DRE.  The DRE 
was performed in the left lateral position by the same investigator.  The PSA 
serum samples were taken 30 minutes before and after the DRE.  The tPSA data 
was presented which showed the change post DRE.  The tPSA for before, after, 
and the change post DRE including the confidence intervals were 8.41 (0.74-
16.07), 9.13 (0.89-17.38), and 0.72 (0.06-1.4), respectively.  The cPSA for 
before, after, and the change were 5.95 (1.11-10.79), 5.98 (1.07-10.9), and 0.03 
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(-0.1-0.17) in that order.  The authors concluded that prostatic manipulation 
results in minimal changes in cPSA levels. 
The final study reviewed was the Lin et al. (2010) study that evaluated 160 
males with a mean age of 68 years.  They set out to determine how various 
forms of prostatic manipulation affect the tPSA and free-to-total prostate specific 
antigen (f/tPSA).  There were a variety of prostatic manipulations which included 
DRE, urethral catheterization, rigid cystoscopy, prostate biopsy, transurethral 
resection of the prostate and suprapubic subcapsular prostatectomy.  Of those 
participants, 23 underwent DRE for BPH.  This study included data on tPSA and 
not cPSA.  Serum PSA was gathered before the manipulation, at 24 hours and at 
4 weeks.  The tPSA, along with the confidence intervals, in ng/mL before, 24 
hours after, and 4 weeks after were 1.96 (1.31-2.61), 1.97 (1.31-2.63), and 1.96 
(1.30-2.62) respectively.  The authors concluded that the DRE has minimal 
effects on tPSA levels.  
DISCUSSION 
Beginning at the age of 50 and based on clinician and patient preference, 
millions of men are evaluated for prostate cancer by having a DRE and tPSA.  
This is done earlier, if prostate cancer runs throughout the family, or if an 
individual is at high risk or has symptoms of poor prostate health.  The tPSA is 
highly variable and unreliable and has a sensitivity and specificity of 20 to 40 
percent (Fischbach & Dunning, 2009). 
In the past, there has been speculation that any type of manipulation on 
the prostate can influence tPSA levels.  Studies have shown that the DRE and 
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tPSA levels can be done in the same visit (Hoffman, 2010).  However, there is 
some variation post manipulation and it would be better to ensure that a test that 
has such a low sensitivity and specificity already, be less influenced by external 
factors.  A false positive test can result in an individual undergoing additional 
testing which may include referrals to urologists, additional blood testing and 
possible biopsies or other invasive procedures.  Certainly this could lead to an 
exponential rise in the individuals’ medical expenditures, but this could also lead 
to the person missing time and money due to lost work as well as burdening the 
individual with undue stress due the potential threat of prostate cancer becoming 
a reality rather than a possibility.  Therefore, it is crucial to improve the reliability 
of the PSA test. 
The complexed PSA is a subset of the total PSA and therefore, it will by 
definition change less numerically in relation to the total PSA.  However, the 
percent change would be a more reliable indicator as how much it would change 
after the prostate had been manipulated and Lynn et al. (2000) and Tarhan et al. 
(2005) demonstrated that the cPSA in relation to tPSA had a percentage change 
of 0.50 and 6.43 compared to 7.89 and 49.00, respectively.  Long et al. (2006) 
also showed a smaller mean change of cPSA in relation to tPSA, but the results 
were highly variable.  Lin et al. (2010) showed that the tPSA undergoes minimal 
change in tPSA 24 hours after a DRE, but the cPSA was not evaluated.  All this 
information combined would suggest that the tPSA is not significantly affected by 
the DRE and the blood tests could be done after the clinical examination.  
However, due to the inherent unreliability of the tPSA test, using the cPSA 
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instead would only improve the reliability of the results leading to fewer false 
positives.  In summary, the cPSA is a more reliable clinical indicator of measuring 
prostate health than the tPSA. 
Study Limitations 
 The Lin et al. (2010) study had 23 individuals which is similar in total to the 
other three studies.  The urologists were instructed to perform a regular DRE 
without vigorous prostatic massage so there was no dose-response curve.  It 
was difficult to determine if their age had any effect on the measurements.  The 
study had a total of 160 individuals in it that had various procedures including the 
23 that had a DRE.  The age range specified for the study was from 50 to 85 with 
a mean age of 68 years old.  The ages were not broken out by who had what 
procedure so it is not evident if age is a factor in how tPSA responds to DRE 
manipulation.  The conclusion of the study was that DRE manipulation resulted in 
no tPSA changes at 24 hours and at one week after a standard DRE was 
performed.   
 The Long et al. (2006) study had 34 participants.  These individuals were 
all examined by the same clinician, but no specific instructions were given to the 
clinician so it was assumed it was a standard DRE and, therefore, no dose 
response curve was evaluated.  As with the other study there was a wide range 
of ages from 29 to 87 years of age.  Since screening for high risk individuals 
begins at 40 it is difficult to determine if age skewed the results.  This study also 
included multiple procedures and actually had 113 patients included in the study 
of whom 34 of the participants were subject to a DRE.  As a result, it is uncertain 
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what factor, age played in the variation of tPSA and cPSA if any.  The results 
were also displayed showing a mean change rather than the raw score.  This 
made it impossible to determine the actual percentage change so it could only be 
said that, without having all the data, the cPSA showed a smaller variation than 
tPSA.  Their conclusion was that cPSA is less prone to variations and is a more 
reliable marker and should be considered to replace tPSA. 
 Tarhan et al. (2005) had 51 males that contributed to the study.  These 
men were given a prostatic massage for approximately one minute by the same 
investigator.  Since all the men received the one minute massage there could be 
no comparison made according to a dose response.  The individual ages, 
according the condition being treated, had been established in this study unlike 
the others.  They were then compared, before and after, according to their 
condition as well as a summarized total.  This study displayed the data in a very 
organized format and was very straight forward, but it is recognized that due to 
the sample size of the study and limit to one variable in terms of length of 
massage, the quality of the evidence remains low.  For instance, it would have 
been helpful to see a standard DRE versus a one minute prostatic massage. The 
overall result of the study is that prostatic massage increased the cPSA, but less 
than tSPA.   
 Finally, Lynn et al. (2000) had 16 participants.  The DRE was carried out 
by the same examiner.  As with the other studies, there is no explanation as to 
how long it took to perform a DRE so no dose response curve could be 
evaluated.  This study actually had 92 members in it of which 16 received a DRE 
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while others underwent other procedures.  The study had a mean age of 68.6 
years with ranges from 66.6 to 70.5 years of age.  Although the age ranges were 
fairly close, it would have been helpful to see the ages broken out by the type of 
procedure they underwent.  The conclusion of the study is that is unclear why 
cPSA levels remain unchanged after prostatic manipulation. 
GRADE Evaluation 
The GRADE system is a tool aimed at using a sensible approach to 
grading the quality of evidence as well as the strength of a recommendation.  
There are four grades in the grade system that include high, moderate, low, and 
very low.  A high grade means that “further research is highly unlikely to change 
the confidence in the estimate of effect” whereas a moderate grade denotes that 
“additional research is likely to have an important impact on the confidence in the 
estimate of effect”  (Guyatt et al., 2008, p.926).  A low grade implies that “further 
research is very likely to have an important impact on the confidence of the 
estimate and is likely to change it” while a very low grade means “signifies the 
effect is uncertain”  (Guyatt et al., 2008, p.926).   All four outcomes used, started 
and ended with a grade of low because they were observational based studies 
that did not merit upgrading based on large magnitude of effect, dose-response, 
and elimination of confounders.  
Conclusions 
 In summary, the effect the DRE has on cPSA is minimal in comparison to 
the tPSA (Appendix B-Figure 1).  All four outcomes were given a low GRADE 
rating and a low grade using the GRADE system means that “further research is 
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very likely to have an important impact on the confidence in the estimate of effect 
and is likely to change the estimate”  (Guyatt et al., 2008, p.926).  Additional well 
designed studies need to be performed to evaluate cPSA replacing tPSA as the 
standard marker to determine prostate health.  This would involve gathering large 
amounts of baseline cPSA data to determine what ranges the test measurement 
would be, to be considered normal and abnormal.  Furthermore, it would be 
beneficial if the individual studies included large sample sizes with varying 
prostatic manipulation times using a randomized double blinded fashion to 
determine how long the prostate is manipulated, has on the effect of the cPSA.  
Additionally, it has been shown that ejaculation may cause an increase in the 
tPSA levels by up to 0.8 ng/mL for up to 48 hours and all of the studies failed to 
include questioning their participants about their sexual history (Hoffman, 2010).  
It would have also been beneficial to know the habits of their participants such as 
bicycling, caffeine and alcohol intake, and smoking status.  The data may not be 
changed by including those questions to future participants, however it ensures 
that additional potential confounders have been accounted for or at least taken 
into consideration.  It has been shown that the DRE has little effect on tPSA 
levels (Hoffman, 2010), nonetheless it would be beneficial to rule out that the 
DRE may affect the tPSA or cPSA levels based on how much manipulation is 
done to the prostate prior to running the test.  This would be very important 
clinically as the investigator may feel an abnormality and spend more time or get 
another opinion of a colleague and unknowingly elevate the results.  Tarhan et al. 
(2005) study manipulated the prostate for one minute and Lynn et al. (2000) 
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performed a standard DRE in which they did not describe the length of time the 
prostate was manipulated.  This could explain the disparity in figure 1 (Appendix 
B). 
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APPENDIX A 
Table 1:  GRADE Table 
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APPENDIX B 
Figure 1:  Percent change in PSA levels 
 
 
Figure 1:  Percent change in PSA levels approximately 30 minutes post Digital Rectal 
Examination.  Figure recreated using data courtesy of Lynn et al. and Tarhan et al. 
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